A DPP6‐Targeted PET Tracer for Non‐Invasive Imaging of Transplanted Human Islets
6 affiliations
- 1Science for Life Laboratory, Department of Medicinal Chemistry Uppsala University Uppsala Sweden
- 2ULB Center for Diabetes Research, Medical Faculty Université Libre De Bruxelles Brussels Belgium
- 3Department of Medical Cell Biology Uppsala University Uppsala Sweden
- 4Department of Medicinal Chemistry Uppsala University Uppsala Sweden
- 5PET Center Uppsala University Hospital Uppsala Sweden
- 6InSphero AG Schlieren Switzerland
Abstract
Introduction: Dipeptidyl peptidase‐like protein 6 (DPP6) is a potential molecular imaging biomarker for pancreatic and transplanted islets of Langerhans. 4hD29 is a single‐domain antibody with nanomolar affinity for DPP6. Here, we demonstrate the generation and validation of [68Ga]Ga‐NOTA‐4hD29 for Positron Emission Tomography (PET) imaging of human stem cell‐derived islets (SC‐islets) and human islets.
Methods: The binding of fluorescently labelled 4hD29 to human islets, human beta cell models and pancreatic tissues from various species over time was characterised. NOTA‐4hD29 was radiolabelled with Gallium‐68, and the resulting tracer [68Ga]Ga‐NOTA‐4hD29 was evaluated for in vitro DPP6 binding as well as in vivo biodistribution. In vivo PET imaging was performed in immunodeficient mice transplanted with 400 to 800 SC‐islets or human islets, and the uptake signal was compared to non‐transplanted control mice.
Results: Fluorescently labelled 4hD29 demonstrated specific binding and internalisation in human islets. Fluorescence signal remained detectable for up to 2 h following incubation, indicating sustained intracellular retention. [68Ga]Ga‐NOTA‐4hD29 bound to human islets with high specificity, and binding intensity correlated to islet purity. The binding of fluorescent and radiolabelled 4hD29 was negligible in extra‐pancreatic tissues. In vivo PET imaging enabled reliable detection of grafts comprised of 400 to 800 SC‐islets or human islets in immunodeficient mice.
Conclusion: [68Ga]Ga‐NOTA‐4hD29 is a promising PET tracer for in vivo imaging of DPP6 in human islets. The tracer enabled non‐invasive detection of transplanted human islet grafts in the 400–800 IEQ range and demonstrated favourable biodistribution and dosimetry profiles, supporting its further development for islet imaging applications.
Related
- Synthesis and Preliminary Biological Evaluation of a Structurally Modified Niraparib-Based PARP-Targeted PET Tracer for Tumor Imaging
- 99mTc-DTPA-OM: Cardiac-Myosin Targeted SPECT agent for Non-Invasive Myocardial Infarction Imaging
- Copper-Mediated Radiofluorination of the Excitatory Amino Acid Transporter 2 (EAAT2)-Targeted PET Tracer [¹⁸F]RP-115: Alternate Synthetic Method.
- Second-generation tau PET tracer in situ binding assessed with fluorescence imaging
- Toward Precision Imaging in Lung NET: A Clinically Oriented Framework Integrating Dual Tracer PET and Radiomics.
BibTeX
@article{khalil2026dpp6targeted,
title = {{A DPP6‐Targeted PET Tracer for Non‐Invasive Imaging of Transplanted Human Islets}},
author = {Amina Khalil and Arturo Roca‐Rivada and Svitlana Vasylovska and Lorenzo J. I. Balestri and Irina Velikyan and Sayro Jawurek and Alexandra C. Title and Burcak Yesildag and Luke R. Odell and Joey Lau and Decio L. Eizirik and Olof Eriksson},
journal = {Diabetes, Obesity \& Metabolism},
year = {2026},
month = sep,
doi = {10.1111/dom.71343},
url = {https://doi.org/10.1111/dom.71343},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - A DPP6‐Targeted PET Tracer for Non‐Invasive Imaging of Transplanted Human Islets
AU - Amina Khalil
AU - Arturo Roca‐Rivada
AU - Svitlana Vasylovska
AU - Lorenzo J. I. Balestri
AU - Irina Velikyan
AU - Sayro Jawurek
AU - Alexandra C. Title
AU - Burcak Yesildag
AU - Luke R. Odell
AU - Joey Lau
AU - Decio L. Eizirik
AU - Olof Eriksson
PY - 2026
DA - 2026/09/20
JO - Diabetes, Obesity & Metabolism
DO - 10.1111/dom.71343
UR - https://doi.org/10.1111/dom.71343
AB - Introduction: Dipeptidyl peptidase‐like protein 6 (DPP6) is a potential molecular imaging biomarker for pancreatic and transplanted islets of Langerhans. 4hD29 is a single‐domain antibody with nanomolar affinity for DPP6. Here, we demonstrate the generation and validation of [68Ga]Ga‐NOTA‐4hD29 for Positron Emission Tomography (PET) imaging of human stem cell‐derived islets (SC‐islets) and human islets. Methods: The binding of fluorescently labelled 4hD29 to human islets, human beta cell models and pancreatic tissues from various species over time was characterised. NOTA‐4hD29 was radiolabelled with Gallium‐68, and the resulting tracer [68Ga]Ga‐NOTA‐4hD29 was evaluated for in vitro DPP6 binding as well as in vivo biodistribution. In vivo PET imaging was performed in immunodeficient mice transplanted with 400 to 800 SC‐islets or human islets, and the uptake signal was compared to non‐transplanted control mice. Results: Fluorescently labelled 4hD29 demonstrated specific binding and internalisation in human islets. Fluorescence signal remained detectable for up to 2 h following incubation, indicating sustained intracellular retention. [68Ga]Ga‐NOTA‐4hD29 bound to human islets with high specificity, and binding intensity correlated to islet purity. The binding of fluorescent and radiolabelled 4hD29 was negligible in extra‐pancreatic tissues. In vivo PET imaging enabled reliable detection of grafts comprised of 400 to 800 SC‐islets or human islets in immunodeficient mice. Conclusion: [68Ga]Ga‐NOTA‐4hD29 is a promising PET tracer for in vivo imaging of DPP6 in human islets. The tracer enabled non‐invasive detection of transplanted human islet grafts in the 400–800 IEQ range and demonstrated favourable biodistribution and dosimetry profiles, supporting its further development for islet imaging applications.
SN - 1462-8902
SN - 1463-1326
ER -